Limited activity: This researcher has not published recently. Profile data may be outdated.
Ren Xu profile photo

Ren Xu Institution-verified

Sourced from institutional research profiles (UAMS TRI or ARA).

◆ ARA Academy Federal Grant PI

Professor

Last refreshed 2026-05-23

faculty

COM | Radiation Oncology

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Ren Xu studies the roles of RORα in breast cancer development and progression. This research is supported by a grant from the NIH/National Cancer Institute, for which Xu serves as PI, totaling $62,602.

Xu is a Professor in the Department of Radiation Oncology at the University of Arkansas for Medical Sciences and an Innovation Scholar in the ARA Academy. Their research area is Cancer Research, and they maintain an active lab website.

ARA Academy 2025 Innovation Scholar

Dr. Xu is a newly appointed division director at the UAMS Cancer Institute. Previously a tenured professor of pharmacology at the University of Kentucky's Markey Cancer Center, his research focuses on microenvironmental cues and their modulation of breast cancer progression, with emphasis on identifying strategies to inhibit breast cancer metastasis and drug resistance. Several junior faculty he mentored have secured NIH R01 and foundation grants. His research has been continuously supported by multiple NCI R01 grants.

Policy Impact

Brings continuous NCI R01 grant funding and cancer research leadership to Arkansas, strengthening UAMS's capacity to compete for federal biomedical research dollars.

Growth Areas

['Population Health Innovations & Clinical Research']

Federal Grants 4 $961,192 total

NIH/National Cancer Institute Contact PI Feb 2026 - Jan 2028

Roles of Hsp47 in breast cancer progression

National Cancer Institute $267,208 R01
NIH/National Cancer Institute Contact PI Dec 2025 - Nov 2028

Roles of mRNA transfer in cancer cell-platelet communication

National Cancer Institute $294,940 R01
NIH/National Cancer Institute Contact PI Sep 2023 - Dec 2028

The PLOD2/succinate axis in regulating cancer cell plasticity and stemness

National Cancer Institute $336,442 R01
NIH/National Cancer Institute Contact PI Jul 2017 - Jun 2026

Roles of RORα in breast cancer development and progression

National Cancer Institute $62,602 R01

Similar Researchers

Based on overlapping research topics